Isotope Standards
Isotope Standards
Eldecalcitol-d6, MedChemExpress
MedChemExpress Eldecalcitol-d6 is the deuterium labeled Eldecalcitol. Eldecalcitol is an orally active analogue of active vitamin D used in the treatment of osteoporosis.
Azilsartan-d5, MedChemExpress
MedChemExpress Azilsartan D5 (TAK-536 D5) is the deuterium labeled Azilsartan(TAK-536), which is a specific and potent angiotensin II type 1 receptor antagonist.
(±)-Levomepromazine-d6, MedChemExpress
MedChemExpress (±)-Levomepromazine D6 ((±)-Methotrimeprazine D6) is the deuterium labeled Methotrimeprazine, which is a D3 dopamine and Histamine H1 receptor antagonist.
Sofosbuvir-d6, MedChemExpress
MedChemExpress Sofosbuvir D6 (PSI-7977 D6) is the deuterium labeled Sofosbuvir. Sofosbuvir (PSI-7977) is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity.
MMAD-d8, MedChemExpress
MedChemExpress D8-MMAD is a deuterated form of MMAD, which is a microtubule disrupting agent.
Fexofenadine-d6, MedChemExpress
MedChemExpress Fexofenadine D6 (MDL-16455 D6) is deuterium labeled is Fexofenadine, which is an antihistamine pharmaceutical agent.
Maxacalcitol-d6, MedChemExpress
MedChemExpress Maxacalcitol-D6 is the deuterated form of Maxacalcitol (22-Oxacalcitriol), which is a non-calcemic vitamin D3 analog and VDR ligand of VDR-like receptors.
Proguanil-d6, MedChemExpress
MedChemExpress Proguanil D6 is the deuterium labeled Proguanil, which is a prophylactic antimalarial drug.
Alfacalcidol-d6, MedChemExpress
MedChemExpress Alfacalcidol-d6 is the deuterium labeled Alfacalcidol. Alfacalcidol is a non-selective VDR activator.
Nepafenac-d5, MedChemExpress
MedChemExpress Nepafenac D5 (AHR-9434 D5) is the deuterium labeled Nepafenac, which is a selective COX-2 inhibitor.
Enalaprilat D5, MedChemExpress
MedChemExpress Enalaprilat D5 (MK-422 D5) is the deuterium labeled Enalaprilat(MK-422), which is an angiotensin-converting enzyme (ACE) inhibitor.
VX-984, MedChemExpress
MedChemExpress VX-984 (M9831) is an orally active, potent, selective and BBB-penetrated DNA-PK inhibitor. VX-984 efficiently inhibits NHEJ (non-homologous end joining) and increases DSBs (DNA double-strand breaks). VX-984 can be used for glioblastomas (GBM) and non-small cell lung cancer (NSCLC) research.